Autor:
Cabrera, D.
Wree, A.
Povero, D.
Solís, N.
Hernandez, A.
Pizarro, M.
Moshage, H.
Torres, J.
Feldstein, A.E.
Cabello-Verrugio, C.
Brandan, E.
Barrera, F.
Arab, J.P.
Arrese, M.
Therapy for nonalcoholic steatohepatitis (NASH) is limited. Andrographolide (ANDRO), a botanical compound, has a potent anti-inflammatory activity due to its ability to inhibit NF-κB. ANDRO has been also shown to inhibit the NLRP3 inflammasome, a relevant pathway in NASH. Our aim was to evaluate ...
Enlace original:
http://repositorio.unab.cl/xmlui/handle/ria/4736
Cabrera, D.
,
Wree, A.
,
Povero, D.
,
Solís, N.
,
Hernandez, A.
,
Pizarro, M.
,
Moshage, H.
,
Torres, J.
,
Feldstein, A.E.
,
Cabello-Verrugio, C.
,
Brandan, E.
,
Barrera, F.
,
Arab, J.P.
,
Arrese, M.
,
[Andrographolide Ameliorates Inflammation and Fibrogenesis and Attenuates Inflammasome Activation in Experimental Non-Alcoholic Steatohepatitis]
,
Andrographolide Ameliorates Inflammation and Fibrogenesis and Attenuates Inflammasome Activation in Experimental Non-Alcoholic Steatohepatitis
